Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:47 AM
Ignite Modification Date:
2025-12-25 @ 3:47 AM
NCT ID:
NCT00060502
Eligibility Criteria:
Inclusion Criteria:
* Patients must have documented diagnosis of pancreatic cancer that is newly diagnosed
* Patients must have documented loss of \>=10% body weight compared to weight prior to diagnosis, or \>=5% weight loss within 90 days prior to randomization
* Patients must have Karnofsky performance status of 70 to 100
* eligible according to country specific tuberculosis (TB) screening rules.
Exclusion Criteria:
* Patients must not have received any previous chemotherapy, biologic therapy or radiation therapy for pancreatic cancer
* Patients must not have a history or current evidence of active TB, skin test or screening evidence of latent TB, or history of treated TB, active or latent
* Patients must not have evidence or history of congestive heart failure
* Patients must not have any opportunistic infection within 6 months prior to screening
* Patients must not be pregnant, nursing or planning pregnancy
* Patients must not have ongoing use of tube feedings or TPN
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00060502
Study Brief:
Protocol Section:
NCT00060502